Literature DB >> 7459224

Hyperphagocytosis and the effect of lipopolysaccharide injection in tumour-bearing mice.

J W Bradfield, T Whitmarsh-Everiss, D B Palmer, R Payne, M O Symes.   

Abstract

(AxT6)F1 hybrid mice received s.c. transplants from (AxT6)F1 mammary carcinomas. At 1, 2 or 4 weeks after tumour transplantation, the mice were bled to obtain plasma and then challenged with 25 micron E. coli lipopolysaccharide (LPS) endotoxin i.v. The mice were killed 24 hr later, further plasma was obtained and their liver ratios and spleen ratios were determined. A similar procedure was carried out on non-tumour-bearing mice. Progressive tumour growth was associated with an increase in the liver ratio. In parallel, mice with 4-week tumour transplant showed increased uptake of colloidal carbon particles and 51Cr-labelled sheep red blood cells in the liver. The plasma amino aspartate transaminase (AST) and the ornithine carbamoyl transferase (OCT) showed a constant rise in all groups of mice after LPS injection. However, at 24 hr after LPS injection, the AST level showed the greatest rise in mice with 4-week tumour transplants. By contrast, OCT, which is liberated only from hepatocytes, showed the greatest rise in non-tumour-bearing mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7459224      PMCID: PMC2010591          DOI: 10.1038/bjc.1980.338

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  The mechanism of the adjuvant effect of dextran sulphate.

Authors:  J W Bradfield; R L Souhami; I E Addison
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

2.  The effect of colloidal carbon on the organ distribution of sheep red cells and the immune response.

Authors:  R L Souhami
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

3.  Macrophage production in response to the growth of an experimental tumour.

Authors:  M Baum; B Fisher
Journal:  Br J Surg       Date:  1972-11       Impact factor: 6.939

4.  Standardization of clinical enzyme assays: a reference method for aspartate and alanine transaminases.

Authors:  J H Wilkinson; D N Baron; D W Moss; P G Walker
Journal:  J Clin Pathol       Date:  1972-11       Impact factor: 3.411

5.  Reticulo-endothelial activity in humans with cancer.

Authors:  C J Magarey; M Baum
Journal:  Br J Surg       Date:  1970-10       Impact factor: 6.939

6.  Detoxification of endotoxin by perfusion of liver and spleen.

Authors:  S Rutenburg; R Skarnes; C Palmerio; J Fine
Journal:  Proc Soc Exp Biol Med       Date:  1967-06

7.  Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice.

Authors:  H Kirchner; H T Holden; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

8.  Cytotoxicity mediated by soluble macrophage product(s).

Authors:  K K Sethi; H Brandis
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

9.  Endotoxin-induced hepatic damage in BCG-infected mice.

Authors:  J W Shands; V C Senterfitt
Journal:  Am J Pathol       Date:  1972-04       Impact factor: 4.307

10.  Activated macrophages release a factor which lyses malignant cells but not normal cells.

Authors:  G A Currie; C Basham
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  1 in total

1.  Further studies on the protection by an F1 tumour against GvHR induced in F1 mice by injection of parental spleen cells.

Authors:  D B Palmer; T Whitmarsh-Everiss; M O Symes
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.